For example, it was reported that dicoumarol and other more specific inhibitors of NQO1 reduce the death of several types of cancer cells [69], and NQO1-deficient mice exhibit enhanced susceptibility to skin cancers [70]. Here, NQO1 is linked to skin neoplasm.